aTyr Pharma
ATYR
#9469
Rank
โ‚น7.22 B
Marketcap
โ‚น73.69
Share price
0.95%
Change (1 day)
-73.61%
Change (1 year)

Revenue for aTyr Pharma (ATYR)

Revenue in 2025 (TTM): โ‚น16.87 Million

According to aTyr Pharma's latest financial reports the company's current revenue (TTM ) is โ‚น17.15 Million. In 2024 the company made a revenue of โ‚น20.15 Million a decrease over the revenue in the year 2023 that were of โ‚น29.38 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for aTyr Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น16.87 M-16.27%
2024 โ‚น20.15 M-31.4%
2023 โ‚น29.38 M-96.58%
2022 โ‚น0.85 B
2021 N/A-100%
2020 โ‚น0.76 B2440.82%
2019 โ‚น30.09 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Veracyte
VCYT
โ‚น44.71 B 260,500.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.058 T 6,170,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA